Neuphoria Therapeutics Inc. (NEUP) quarterly cash flow statement — complete operating, investing & financing history
Neuphoria Therapeutics Inc. (NEUP) cash flow statement — 27-year operating, investing & financing cash flows
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|
| Cash from Operations | 1.19M | -3.87M | -6.44M | -3.79M | 73.57M | 11.45M | -3.36M | -4.43M | -3.01M | -3.3M | -3.95M | -4.43M |
| Operating CF Margin % | 101.14% | - | - | - | -702.48% | 45.72% | -313.67% | - | - | - | - | - |
| Operating CF Growth % | -98.39% | -133.8% | -91.66% | 14.4% | 2543.43% | 447.59% | 14.88% | -0.07% | - | - | - | - |
| Net Income | -13.44B | -505.06K | 1.86M | -9.91M | -378.15M | 11.26M | -1.94M | -805K | -2.69M | -2.78M | -4.55M | -5.47M |
| Depreciation & Amortization | 662.46M | 165.69K | 165.79K | 165.79K | 662.39M | 165.43K | 166.12K | 165.71K | 165.69K | 165.7K | 165.69K | 165.91K |
| Stock-Based Compensation | 351.32M | 0 | 93.7K | 111.28K | 163.71M | 19.68K | 19.08K | 26.74K | 107.72K | 17.38K | 556.98K | 132.74K |
| Deferred Taxes | -139.03M | -38.93K | -69.59K | 0 | -468.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 12.57B | -1.17M | -3.37M | 4.44M | 91.87M | 648.69K | -1.27M | -2.62M | -2.85M | 405.8K | 98.96K | 228.04K |
| Working Capital Changes | 98.09K | -2.32M | -5.12M | 1.4M | 2.17M | -642.52K | -328K | -1.2M | 2.26M | -1.11M | -212.34K | 516.08K |
| Change in Receivables | 819.33K | -558.5K | -1.66M | 10.19K | 114.83M | 10.97K | 80.4K | 10.92K | -21.18K | 9.64K | 326.99K | -16.25K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -256.18K | 86.1K | -1.28M | 216.36K | -916.16M | -785.33K | 204.67K | -918K | 1.66M | -865.56K | -874K | 880.61K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | 0% | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 109.95K | 698.95K | 14.66M | 3.25M | 1.53B | 1.16M | -107.1K | -227K | 7.12M | 1.75M | 5.63M | 612.54K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 109.95K | 698.95K | 22.01M | 3.25M | -794.29K | 823.6K | -107.1K | -227K | 2.12M | 1.44M | 288.78K | 6.26M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -7.35M | 0 | 1.53B | 338.9K | 0 | 0 | 5M | 311.43K | 5.34M | -5.65M |
| Net Change in Cash | 424.88K | -2.81M | 8.52M | -3.32M | 14.27B | 12.7M | -3.75M | -4.52M | 4.18M | -1.73M | 2.02M | -3.97M |
| Free Cash Flow | -12.34B | -3.87M | -6.44M | -3.79M | 73.57M | 11.45M | -3.36M | -4.43M | -3.01M | -3.3M | -3.95M | -4.43M |
| FCF Margin % | -1050917.64% | - | - | - | -702.48% | 45.72% | -313.67% | - | - | - | - | - |
| FCF Growth % | -16873.26% | -133.8% | -91.66% | 14.4% | 2543.43% | 447.59% | 14.88% | -0.07% | - | - | - | - |
| FCF per Share | -2280.31 | -0.72 | -1.42 | -1.69 | 45.33 | 0.05 | -0.01 | -0.02 | -0.03 | -0.02 | -0.03 | -0.04 |
| FCF Conversion (FCF/Net Income) | -0.24x | 7.67x | -2.30x | 0.25x | -4.95x | 0.61x | 1.07x | 3.74x | 0.75x | 0.77x | 0.59x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |